During the past decade, Institut de Rhumatologie de Montreal conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 8 clinical trials were completed, i.e. on average, 266.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut de Rhumatologie de Montreal" #1 sponsor was "Pfizer" with 3 trials, followed by "Amgen" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Pope Research Corporation" with 2 trials sponsored and "ArthroLab Inc." with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut de Rhumatologie de Montreal" #1 collaborator was "Amgen" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Institut de Rhumatologie de Montreal" are "Rheumatoid Arthritis" (6 trials), "Knee Osteoarthritis" (3 trials), "Psoriatic Arthritis" (2 trials), "Ankylosing Spondylitis" (1 trials) and "Arthritis, Psoriatic" (1 trials). Many other conditions were trialed in "Institut de Rhumatologie de Montreal" in a lesser frequency.

Most popular intervention types in "Institut de Rhumatologie de Montreal" are "Drug" (10 trials), "Other" (3 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Methotrexate" (3 trials), "Placebo" (3 trials), "Tocilizumab" (2 trials), "Abatacept" (1 trials) and "Adalimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut de Rhumatologie de Montreal" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Institut de Rhumatologie de Montreal". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Institut de Rhumatologie de Montreal, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Institut de Rhumatologie de Montreal, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".